Clinical Trials Browser

Phase 2/3 × Dyspnea × 90 days × Clear all

NCT06336642 2026-03-10

Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology

Phase 2/3 Recruiting

Dyspnea